In July 2013, the WHO released new Consolidated Guidelines for the use of Antiretroviral Drugs for Treating and Prevention of HIV Infection. The 2013 WHO guidelines advocate for the use of ARVs within a broad continuum of care and include guidance for implementation and M&E. This strategy of harmonization, integration and simplification follows the same principles that were introduced in the 1st Edition of the Malawi Guidelines in 2011.